Cencora, Inc. (COR)
- Previous Close
222.92 - Open
223.18 - Bid 136.30 x 1000
- Ask 227.39 x 800
- Day's Range
220.68 - 223.71 - 52 Week Range
163.37 - 246.75 - Volume
1,341,421 - Avg. Volume
1,237,949 - Market Cap (intraday)
44.266B - Beta (5Y Monthly) 0.47
- PE Ratio (TTM)
24.28 - EPS (TTM)
9.14 - Earnings Date Jul 31, 2024 - Aug 5, 2024
- Forward Dividend & Yield 2.04 (0.92%)
- Ex-Dividend Date May 9, 2024
- 1y Target Est
258.07
Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
www.cencora.com46,000
Full Time Employees
September 30
Fiscal Year Ends
Sector
Industry
Recent News: COR
Performance Overview: COR
Trailing total returns as of 5/14/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: COR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: COR
Valuation Measures
Market Cap
44.46B
Enterprise Value
47.64B
Trailing P/E
24.39
Forward P/E
16.72
PEG Ratio (5yr expected)
2.02
Price/Sales (ttm)
0.16
Price/Book (mrq)
41.05
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.67%
Return on Assets (ttm)
2.88%
Return on Equity (ttm)
213.15%
Revenue (ttm)
276.54B
Net Income Avi to Common (ttm)
1.85B
Diluted EPS (ttm)
9.14
Balance Sheet and Cash Flow
Total Cash (mrq)
2.07B
Total Debt/Equity (mrq)
543.70%
Levered Free Cash Flow (ttm)
2.68B
Research Analysis: COR
Company Insights: COR
COR does not have Company Insights